Episode notes
What if AI could help us discover new medicines faster, more accurately, and with greater impact for patients?
In this episode of AI at Work, I speak with Dr. Chris Austin, Head of Research Technologies at GSK, to explore how artificial intelligence is changing the way new treatments are developed. Chris brings a unique perspective shaped by decades of experience across academia, biotech, government, and now big pharma. His mission at GSK is clear: to bring science, technology, and talent together to radically improve human health.
We unpack how AI, combined with massive clinical and genetic datasets, is enabling GSK to target disease with unprecedented precision. From identifying the right molecular pathways to simulating clinical trials using digital twins, Chris walks us through how technology is helping reduce development ...
Keywords
GSK